tiprankstipranks
Genscript Biotech Corporation (GNNSF)
:GNNSF
US Market

Genscript Biotech (GNNSF) Income Statement

Compare
16 Followers

Genscript Biotech Income Statement

Last quarter (Q2 2024), Genscript Biotech's total revenue was $561.37M, an increase of 81.33% from the same quarter last year. In Q2, Genscript Biotech's net income was $-175.12M. See Genscript Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 839.53M$ 625.70M$ 490.10M$ 390.85M$ 273.35M
Gross Profit
$ 409.55M$ 304.08M$ 282.52M$ 255.89M$ 180.29M
Operating Expenses
$ 409.55M$ 735.72M$ 804.05M$ 544.38M$ 301.55M
Depreciation and Amortization
$ 74.05M$ 64.25M$ 47.78M$ 32.90M$ 20.64M
EBITDA
$ -249.42M$ -389.04M$ -341.57M$ -174.71M$ -112.36M
Operating Income
$ -415.79M$ -438.11M$ -379.29M$ -204.55M$ -131.35M
Other Income/Expenses
$ 64.81M$ -3.93M$ -138.07M$ -77.35M$ 9.69M
Pretax Income
$ -350.98M$ -431.69M$ -517.36M$ -281.90M$ -113.69M
Net Income
$ -95.48M$ -226.85M$ -358.71M$ -204.94M$ -96.91M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.05$ -0.11$ -0.18$ -0.11$ -0.05
Diluted EPS
$ -0.05$ -0.11$ -0.18$ -0.11$ -0.05
Weighted Average Shares Outstanding
2.11B 2.10B 2.03B 1.90B 1.85B
Weighted Average Shares Outstanding (Diluted)
2.11B 2.10B 2.03B 1.90B 1.85B
Currency in USD

Genscript Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis